Professor of Neurology, Johns Hopkins University School of Medicine; Director, Division of Neuroimmunology, Director, The Johns Hopkins Multiple Sclerosis Center
Neurology
Dr. Peter A. Calabresi, MD
|
|
Give Review
Peter A. Calabresi, MD is an expert in the field of Neurology. He went to Warren Alpert Medical School of Brown University. He received awards:"America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "Top Doctors:Baltimore Area" and "Top Doctors:Washington-Baltimore". Peter Calabresi is a published MD. He has 103 papers published. The most current publication "Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study." He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Phenytoin in acute Optic neuritis: neuroprotective or not?
- Optical coherence tomography reflects brain atrophy in MS: A four year study.
- Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple Sclerosis.
- 1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in Multiple sclerosis patients and healthy controls.
- Novel therapies for memory cells in autoimmune diseases.
- Automatic segmentation of microcystic macular edema in OCT.
- Single-use autoinjector for peginterferon-β1a treatment of relapsing-remitting Multiple sclerosis: safety, tolerability and patient evaluation data from the Phase IIIb...
- Retinal Damage and Vision Loss in African-American Multiple Sclerosis Patients.
- Mesenchymal Stem Cells Differentially Modulate Effector CD8+ T Cell Subsets and Exacerbate Experimental Autoimmune Encephalomyelitis.
- Hiding in plain sight: a closer look at posterior cortical atrophy.
- Cerebrospinal fluid ceramides from patients with Multiple sclerosis impair neuronal bioenergetics.
- Defining the clinical course of Multiple sclerosis: The 2013 revisions.
- FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway.
- A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation.
- The Impact of Dynamic Balance Measures on Walking Performance in Multiple Sclerosis.
- Pegylated interferon beta-1a for relapsing-remitting Multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study.
- Retinal architecture and mfERG: Optic nerve head component response characteristics in MS.
- Multiple-object geometric deformable model for segmentation of macular OCT.
- Daclizumab-induced adverse events in Multiple organ systems in Multiple sclerosis.
- 1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization.
- Reconstruction of the human cerebral cortex robust to white matter lesions: Method and validation.
- Emerging injectable therapies for Multiple sclerosis.
- Optical coherence tomography in x-linked adrenoleukodystrophy.
- Baseline Retinal Nerve Fiber Layer Thickness and Macular Volume Quantified by OCT in the North American Phase 3 Fingolimod Trial for Relapsing-Remitting Multiple Scler...
- Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein.
- Optic nerve head component responses of the multifocal electroretinogram in MS.
- Retinal layer segmentation of macular OCT images using boundary classification.
- Helper T cells down-regulate CD4 expression upon chronic stimulation giving rise to double-negative T cells.
- Accelerated axon loss in MOG35-55 experimental autoimmune encephalomyelitis (EAE) in myelin-associated glycoprotein-deficient (MAGKO) mice.
- Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric Multiple sclerosis.
- Multiparametric MRI correlates of sensorimotor function in the spinal cord in Multiple sclerosis.
- In vivo identification of morphologic retinal abnormalities in neuromyelitis Optica.
- Quantitative MRI demonstrates Abnormality of the fornix and cingulum in multiple sclerosis.
- Segmentation of retinal OCT images using a random forest classifier.
- Blockade of Kv1.3 Potassium Channels Inhibits Differentiation and Granzyme B Secretion of Human CD8+ T Effector Memory Lymphocytes.
- Interferon beta use and disability prevention in relapsing-remitting Multiple sclerosis.
- Tract-specific quantitative MRI better correlates with disability than conventional MRI in Multiple sclerosis.
- Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning.
- Comparison of point estimates and average thicknesses of retinal layers measured using manual Optical coherence tomography segmentation for quantification of retinal n...
- Expression of CCR7 and CD45RA in CD4(+) and CD8(+) subsets in cerebroSpinal fluid of 134 patients with inflammatory and non-inflammatory neurological diseases.
- Revisiting brain atrophy and its relationship to disability in Multiple sclerosis.
- New and emerging disease modifying therapies for Multiple sclerosis.
- Detection of clinical and subclinical retinal abnormalities in neurosarcoidosis with Optical coherence tomography.
- PEGylation of Interferon-?-1a: A Promising Strategy in Multiple Sclerosis.
- Decreased microglial activation in MS patients treated with glatiramer acetate.
- Inflammation in Multiple sclerosis--sorting out the gray matter.
- Functional blockade of the voltage-gated potassium channel Kv1.3 mediates reversion of T effector to central memory lymphocytes through SMAD3/P21cip1 signaling.
- Ocrelizumab in relapsing-remitting Multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.
- Optical coherence tomography segmentation reveals ganglion cell layer pathology after Optic neuritis.
- NMDA Receptor Signaling in Oligodendrocyte Progenitors Is Not Required for Oligodendrogenesis and Myelination.
- Visual dysfunction in Multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapill...
- Retinal Ganglion Cell Layer Volumetric Assessment by Spectral-Domain Optical Coherence Tomography in Multiple Sclerosis: Application of a High-Precision Manual Estimat...
- In vivo and ex vivo diffusion tensor imaging of cuprizone-induced demyelination in the mouse corpus callosum.
- Probing mouse brain microstructure using oscillating gradient diffusion MRI.
- One Eye or Two: A Comparison of Binocular and Monocular Low-Contrast Acuity Testing in Multiple Sclerosis.
- Diffusion tensor imaging of the optic tracts in Multiple sclerosis: association with retinal thinning and visual disability.
- Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.
- The impact of utilizing different optical coherence tomography devices for clinical purposes and in Multiple sclerosis trials.
- Cutting edge: The transcription factor Kruppel-like factor 4 regulates the differentiation of Th17 cells independently of RORγt.
- FLT-3 expression and function on microglia in Multiple sclerosis.
- Longitudinal study of vision and retinal nerve fiber layer thickness in Multiple sclerosis.
- q-space and conventional diffusion imaging of axon and myelin damage in the rat Spinal cord after axotomy.
- Activated T-cells inhibit neurogenesis by releasing granzyme B: rescue by Kv1.3 blockers.
- Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
- Automated vs. conventional tractography in Multiple sclerosis: variability and correlation with disability.
- A topology-preserving approach to the segmentation of brain images with Multiple sclerosis lesions.
- Macular volume determined by optical coherence tomography as a measure of neuronal loss in Multiple sclerosis.
- Damage to the optic radiation in Multiple sclerosis is associated with retinal injury and visual disability.
- Sensorimotor dysfunction in Multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in the spinal cord.
- Signal transduction inhibition of APCs diminishes th17 and Th1 responses in experimental autoimmune encephalomyelitis.
- Diffusion tensor magnetic resonance imaging of Wallerian degeneration in rat Spinal cord after dorsal root axotomy.
- Natalizumab: bound to rebound?
- Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS.
- Axonal protective effects of the myelin-associated glycoprotein.
- A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in Multiple sclerosis.
- Reproducibility of optical coherence tomography in Multiple sclerosis.
- Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive Multiple sclerosis.
- Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in Multiple sclerosis.
- High b-value q-space diffusion-weighted MRI of the human cervical spinal cord in vivo: feasibility and application to Multiple sclerosis.
- The diagnosis of MS: white spots and red flags.
- Future research directions in Multiple sclerosis therapies.
- Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification.
- Multiparametric magnetic resonance imaging analysis of the corticospinal tract in Multiple sclerosis.
- Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes.
- Dendritic cells are abundant in non-lesional gray matter in Multiple sclerosis.
- Agar-gelatin for embedding tissues prior to paraffin processing.
- Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.
- Pulsed magnetization transfer imaging with body coil transmission at 3 Tesla: feasibility and application.
- Potassium channels Kv1.3 and Kv1.5 are expressed on blood-derived dendritic cells in the central nervous system.
- Unmasking of autoimmune hepatitis in a patient with MS following interferon beta therapy.
- Granzyme B mediates neurotoxicity through a G-protein-coupled receptor.
- Cleavage of cystatin C in the cerebrospinal fluid of patients with Multiple sclerosis.
- Relation of visual function to retinal nerve fiber layer thickness in Multiple sclerosis.
- Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease.
- IL-6 induces regionally selective Spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis.
- The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in Multiple sclerosis brain.
- Bystander modulation of chemokine receptor expression on peripheral blood T lymphocytes mediated by glatiramer therapy.
- Anti-alpha4 integrin therapy for Multiple sclerosis: mechanisms and rationale.
- Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases.
- Diagnosis and management of Multiple sclerosis.
- Retinal degeneration in primary-progressive Multiple sclerosis: A role for cortical lesions?
- Retinal thickness measured with optical coherence tomography and risk of disability worsening in Multiple sclerosis: a cohort study.
Schools
Brown University Alpert Medical School
Strong Mem Hsp University Rochester
Conditions Treated
- Ataxia
- Convulsions
- Gait Abnormality
- Intervertebral Disc Herniation
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Top Doctors:Baltimore Area
- Top Doctors:Washington-Baltimore
Education
-
University of Rochester -
Warren Alpert Medical School of Brown University
Hospital
-
Johns Hopkins Bayview Medical Center -
Johns Hopkins Hospital
Drug Facts
| NPI NUMBER | 1174581250 | |
| NPPES Provider LastName | CALABRESI | |
| NPPES Provider FirstName | PETER | |
| NPPES Provider ZIPCode | 212870005 | |
| NPPES Provider State | MD | |
| Specialty Description | Neurology | |
| Total Claim Count | 188.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1174581250 |
| Last Name Of The Provider | CALABRESI |
| First Name Of The Provider | PETER |
| View All |
Similar Doctors
|
|
Dr. Paul D. Dash, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adrian J. Goldszmidt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irene C. Cortese, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jaishri O. Blakeley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nishiena Gandhi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raya Massoud, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Friedrich R. Von Coelln, MD |
|
|
Dr. Mohamed A. Jamaldeen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Olga P. Fermo, MD |
|
|
Dr. Lenora A. Higginbotham, MD |
|
|
Dr. Joel R. Nunez Gonzalez, MD |
|
|
Dr. Alan S. Greenberg, MD |
|
|
Dr. Payam Mohassel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charlotte J. Sumner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Ernst F L. Niedermeyer |